journal article·2022-12-30Open access

Updated Perspectives on Direct Vascular Cellular Reprogramming and Their Potential Applications in Tissue Engineered Vascular Grafts

Saneth Gavishka Sellahewa, Jojo Yijiao Li, Qingzhong Xiao

Abstract

Cardiovascular disease is a globally prevalent disease with far-reaching medical and socio-economic consequences. Although improvements in treatment pathways and revascularisation therapies have slowed disease progression, contemporary management fails to modulate the underlying atherosclerotic process and sustainably replace damaged arterial tissue. Direct cellular reprogramming is a rapidly evolving and innovative tissue regenerative approach that holds promise to restore functional vasculature and restore blood perfusion. The approach utilises cell plasticity to directly convert somatic cells to another cell fate without a pluripotent stage. In this narrative literature review, we comprehensively analyse and compare direct reprogramming protocols to generate endothelial cells, vascular smooth muscle cells and vascular progenitors. Specifically, we carefully examine the reprogramming factors, their molecular mechanisms, conversion efficacies and therapeutic benefits for each induced vascular cell. Attention is given to the application of these novel approaches with tissue engineered vascular grafts as a therapeutic and disease-modelling platform for cardiovascular diseases. We conclude with a discussion on the ethics of direct reprogramming, its current challenges, and future perspectives.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Pluripotent Stem Cells Research · Electrospun Nanofibers in Biomedical Applications · Tissue Engineering and Regenerative Medicine

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK

Key Laboratory of Cardiovascular Diseases, School of Basic Medical Sciences, Guangzhou Institute of Cardiovascular Disease, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou 511436, China

Funding

British Heart Foundation · National Institute for Health Research Biomedical Research Centre at Barts

References (100+)

Show source-provided references
1. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study10.1016/j.jacc.2020.11.010 ↗
2. Management and Prevention of Saphenous Vein Graft Failure: A Review10.1007/s40119-017-0094-6 ↗
3. Understanding Saphenous Vein Graft Patency10.1161/CIRCULATIONAHA.111.039842 ↗
4. The tissue-engineered vascular graft—Past, present, and future10.1089/ten.teb.2015.0100 ↗
5. Direct cell reprogramming: Approaches, mechanisms and progress10.1038/s41580-021-00335-z ↗
6. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors10.1016/j.cell.2006.07.024 ↗
7. Direct reprogramming into endothelial cells: A new source for vascular regeneration10.2217/rme-2017-0022 ↗
8. Conversion of human fibroblasts to angioblast-like progenitor cells10.1038/nmeth.2255 ↗
9. Transdifferentiation of human fibroblasts to endothelial cells role of innate immunity10.1161/CIRCULATIONAHA.113.007394 ↗
10. Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels10.1073/pnas.1205526109 ↗
11. Conversion of Human Fibroblasts to Functional Endothelial Cells by Defined Factors10.1161/ATVBAHA.112.301167 ↗
12. Transdifferentiated Human Vascular Smooth Muscle Cells are a New Potential Cell Source for Endothelial Regeneration10.1038/s41598-017-05665-7 ↗
13. DKK3 (Dikkopf-3) Transdifferentiates Fibroblasts Into Functional Endothelial Cells—Brief Report10.1161/ATVBAHA.118.311919 ↗
14. Efficient Direct Reprogramming of Mature Amniotic Cells into Endothelial Cells by ETS Factors and TGFβ Suppression10.1016/j.cell.2012.09.032 ↗
15. Therapeutic transdifferentiation of human fibroblasts into endothelial cells using forced expression of lineage-specific transcription factors10.1177/2041731416628329 ↗
16. cAMP/EPAC Signaling Enables ETV2 to Induce Endothelial Cells with High Angiogenesis Potential10.1016/j.ymthe.2019.11.019 ↗
17. ETS transcription factor ETV2 directly converts human fibroblasts into functional endothelial cells10.1073/pnas.1413234112 ↗
18. Direct Reprogramming of Human Dermal Fibroblasts Into Endothelial Cells Using ER71/ETV210.1161/CIRCRESAHA.116.309833 ↗
19. A miRNA cassette reprograms smooth muscle cells into endothelial cells10.1096/fj.202101872R ↗
20. Induction of Vascular Progenitor Cells From Endothelial Cells Stimulates Coronary Collateral Growth10.1161/CIRCRESAHA.111.250126 ↗
21. Developmental origin of smooth muscle cells in the descending aorta in mice10.1242/dev.020958 ↗
22. Notch signalling: A simple pathway becomes complex10.1038/nrm2009 ↗
23. Cheng, Y., Gu, W., Zhang, G., and Guo, X. (2022). Notch1 activation of Jagged1 contributes to differentiation of mesenchymal stem cells into endothelial cells under cigarette smoke extract exposure. BMC Pulm. Med., 22.10.1186/s12890-022-01913-3 ↗
24. Notch Activation of Jagged1 Contributes to the Assembly of the Arterial Wall10.1161/CIRCULATIONAHA.111.047159 ↗
25. Notch Signaling in Vascular Endothelial Cells, Angiogenesis, and Tumor Progression: An Update and Prospective10.3389/fcell.2021.642352 ↗
26. STAT3 and Endothelial Cell—Cardiomyocyte Dialog in Cardiac Remodeling10.3389/fcvm.2019.00050 ↗
27. Lentiviral Vectors and Adeno-Associated Virus Vectors: Useful Tools for Gene Transfer in Pain Research10.1002/ar.23723 ↗
28. A Cytokine-Like Protein Dickkopf-Related Protein 3 Is Atheroprotective10.1161/CIRCULATIONAHA.117.027690 ↗
29. ETV2 functions as a pioneer factor to regulate and reprogram the endothelial lineage10.1038/s41556-022-00901-3 ↗
30. Injury-Mediated Vascular Regeneration Requires Endothelial ER71/ETV210.1161/ATVBAHA.115.306430 ↗
31. Endothelialization and altered hematopoiesis by persistent Etv2 expression in mice10.1016/j.exphem.2012.05.012 ↗
32. Etv2 as an essential regulator of mesodermal lineage development10.1093/cvr/cvx133 ↗
33. Sox17 drives functional engraftment of endothelium converted from non-vascular cells10.1038/ncomms13963 ↗
34. Direct Conversion of Adult Skin Fibroblasts to Endothelial Cells by Defined Factors10.1161/CIRCULATIONAHA.113.007727 ↗
35. Hywood, J.D., Sadeghipour, S., Clayton, Z.E., Yuan, J., Stubbs, C., Wong, J.W.T., Cooke, J.P., and Patel, S. (2021). Induced endothelial cells from peripheral arterial disease patients and neonatal fibroblasts have comparable angiogenic properties. PLoS ONE, 16.10.1371/journal.pone.0255075 ↗
36. Progress in heterologous biosynthesis of forskolin10.1093/jimb/kuab009 ↗
37. Salehi, B., Staniak, M., Czopek, K., Stępień, A., Dua, K., Wadhwa, R., Chellappan, D.K., Sytar, O., Brestic, M., and Bhat, N.G. (2019). The Therapeutic Potential of the Labdane Diterpenoid Forskolin. Appl. Sci., 9.10.3390/app9194089 ↗
38. Adaptable haemodynamic endothelial cells for organogenesis and tumorigenesis10.1038/s41586-020-2712-z ↗
39. Glycolytic Switch Is Required for Transdifferentiation to Endothelial Lineage10.1161/CIRCULATIONAHA.118.035741 ↗
40. Transdifferentiation Requires iNOS Activation10.1161/CIRCRESAHA.116.308263 ↗
41. The multifaceted roles of microRNAs in differentiation10.1016/j.ceb.2020.08.015 ↗
42. ICAM-1 signaling in endothelial cells10.1016/S1734-1140(09)70004-0 ↗
43. Kong, D.-H., Kim, Y.K., Kim, M.R., Jang, J.H., and Lee, S. (2018). Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer. Int. J. Mol. Sci., 19.10.3390/ijms19041057 ↗
44. Fontaine, M., Herkenne, S., Ek, O., Paquot, A., Boeckx, A., Paques, C., Nivelles, O., Thiry, M., and Struman, I. (2021). Extracellular Vesicles Mediate Communication between Endothelial and Vascular Smooth Muscle Cells. Int. J. Mol. Sci., 23.10.3390/ijms23010331 ↗
45. Smooth Muscle Cells Differentiated From Reprogrammed Embryonic Lung Fibroblasts Through DKK3 Signaling Are Potent for Tissue Engineering of Vascular Grafts10.1161/CIRCRESAHA.111.300415 ↗
46. Regulation and characteristics of vascular smooth muscle cell phenotypic diversity10.1007/BF03085963 ↗
47. DKK3 (Dickkopf 3) Alters Atherosclerotic Plaque Phenotype Involving Vascular Progenitor and Fibroblast Differentiation Into Smooth Muscle Cells10.1161/ATVBAHA.117.310079 ↗
48. Direct Reprogramming of Fibroblasts Into Smooth Muscle-Like Cells With Defined Transcription Factors—Brief Report10.1161/ATVBAHA.118.310870 ↗
49. Identification of a Klf4-dependent upstream repressor region mediating transcriptional regulation of the myocardin gene in human smooth muscle cells10.1016/j.bbagrm.2013.09.002 ↗
50. Angiogenic Factor With G Patch and FHA Domains 1 Is a Novel Regulator of Vascular Injury10.1161/ATVBAHA.117.308992 ↗
51. Vascular Wall Progenitor Cells in Health and Disease10.1161/CIRCRESAHA.116.305368 ↗
52. SOX17 Regulates Conversion of Human Fibroblasts Into Endothelial Cells and Erythroblasts by Dedifferentiation Into CD34 + Progenitor Cells10.1161/CIRCULATIONAHA.116.025722 ↗
53. Expandable Cardiovascular Progenitor Cells Reprogrammed from Fibroblasts10.1016/j.stem.2016.02.001 ↗
54. Significant improvement of direct reprogramming efficacy of fibroblasts into progenitor endothelial cells by ETV2 and hypoxia10.1186/s13287-016-0368-2 ↗
55. Etv2- and Fli1-Induced Vascular Progenitor Cells Enhance Functional Recovery in Ischemic Vascular Disease Model—Brief Report10.1161/ATVBAHA.119.313684 ↗
56. Concise Review: Evidence for CD34 as a Common Marker for Diverse Progenitors10.1002/stem.1661 ↗
57. Production of endothelial progenitor cells from skin fibroblasts by direct reprogramming for clinical usages10.1007/s11626-016-0106-1 ↗
58. The Use of Fetal Bovine Serum: Ethical or Scientific Problem?10.1177/026119290203000208 ↗
59. Tissue engineered vascular grafts transform into autologous neovessels capable of native function and growth10.1038/s43856-021-00063-7 ↗
60. Mallis, P., Kostakis, A., Stavropoulos-Giokas, C., and Michalopoulos, E. (2020). Future Perspectives in Small-Diameter Vascular Graft Engineering. Bioengineering, 7.10.3390/bioengineering7040160 ↗
61. Matsuzaki, Y., John, K., Shoji, T., and Shinoka, T. (2019). The Evolution of Tissue Engineered Vascular Graft Technologies: From Preclinical Trials to Advancing Patient Care. Appl. Sci., 9.10.3390/app9071274 ↗
62. Autologous endothelialized small-caliber vascular grafts engineered from blood-derived induced pluripotent stem cells10.1016/j.actbio.2019.07.032 ↗
63. Challenges and Possibilities of Cell-Based Tissue-Engineered Vascular Grafts10.34133/2021/1532103 ↗
64. History, progress and future challenges of artificial blood vessels: A narrative review
65. Bioengineering artificial blood vessels from natural materials10.1016/j.tibtech.2021.11.003 ↗
66. Considerations in the Development of Small-Diameter Vascular Graft as an Alternative for Bypass and Reconstructive Surgeries: A Review10.1007/s13239-020-00482-y ↗
67. Applications of decellularized materials in tissue engineering: Advantages, drawbacks and current improvements, and future perspectives10.1039/D0TB01534B ↗
68. Bioengineering platforms for cell therapeutics derived from pluripotent and direct reprogramming10.1063/5.0040621 ↗
69. Extracellular matrix grafts: From preparation to application (Review)10.3892/ijmm.2020.4818 ↗
70. Decellularized blood vessel development: Current state-of-the-art and future directions10.3389/fbioe.2022.951644 ↗
71. Khanna, A., Zamani, M., and Huang, N.F. (2021). Extracellular Matrix-Based Biomaterials for Cardiovascular Tissue Engineering. J. Cardiovasc. Dev. Dis., 8.10.3390/jcdd8110137 ↗
72. Transdifferentiation of human endothelial progenitors into smooth muscle cells10.1016/j.biomaterials.2016.01.066 ↗
73. Three-dimensional brain-like microenvironments facilitate the direct reprogramming of fibroblasts into therapeutic neurons10.1038/s41551-018-0260-8 ↗
74. Vascularized Liver Organoids Generated Using Induced Hepatic Tissue and Dynamic Liver-Specific Microenvironment as a Drug Testing Platform10.1002/adfm.201801954 ↗
75. Vascular Tissue Engineering: Advanced Techniques and Gene Editing in Stem Cells for Graft Generation10.1089/ten.teb.2019.0264 ↗
76. Decellularized Arterial Extracellular Matrix-Based Hydrogel Supports 3D Bioprinting of the Media Layer of Small-Caliber Blood Vessels|Circulation
77. Cell reprogramming by 3D bioprinting of human fibroblasts in polyurethane hydrogel for fabrication of neural-like constructs10.1016/j.actbio.2018.01.044 ↗
78. Mechanical stimulation enhances development of scaffold-free, 3D-printed, engineered heart tissue grafts10.1002/term.3188 ↗
79. Nanogel tectonic porous 3D scaffold for direct reprogramming fibroblasts into osteoblasts and bone regeneration10.1038/s41598-018-33892-z ↗
80. Engineering vascular tissue with functional smooth muscle cells derived from human iPS cells and nanofibrous scaffolds10.1016/j.biomaterials.2014.07.011 ↗
81. Generation and transplantation of reprogrammed human neurons in the brain using 3D microtopographic scaffolds10.1038/ncomms10862 ↗
82. Fabrication and Characterization of Pectin Hydrogel Nanofiber Scaffolds for Differentiation of Mesenchymal Stem Cells into Vascular Cells10.1021/acsbiomaterials.9b01178 ↗
83. Liu, C., Huang, Y., Pang, M., Yang, Y., Linshan, L., Liu, L., Shu, T., Zhou, W., Wang, X., and Rong, L. (2015). Tissue-Engineered Regeneration of Completely Transected Spinal Cord Using Induced Neural Stem Cells and Gelatin-Electrospun Poly (Lactide-Co-Glycolide)/Polyethylene Glycol Scaffolds. PLoS ONE, 10.10.1371/journal.pone.0117709 ↗
84. Fabrication and surface modification of poly lactic acid (PLA) scaffolds with epidermal growth factor for neural tissue engineering10.1080/21592535.2016.1231276 ↗
85. Ethical Issues in Stem Cell Research10.1210/er.2008-0031 ↗
86. Direct Reprogramming and Ethics in Stem Cell Research10.5840/ncbq20088258 ↗
87. Cellular reprogramming: Mathematics meets medicine10.1002/wsbm.1515 ↗
88. Computational approaches for direct cell reprogramming: From the bulk omics era to the single cell era10.1093/bfgp/elac008 ↗
89. TRANSDIRE: Data-driven direct reprogramming by a pioneer factor-guided trans-omics approach10.1093/bioinformatics/btac209 ↗
90. A predictive computational framework for direct reprogramming between human cell types10.1038/ng.3487 ↗
91. Algorithm for cellular reprogramming10.1073/pnas.1712350114 ↗
92. Gam, R., Sung, M., and Pandurangan, A.P. (2019). Experimental and Computational Approaches to Direct Cell Reprogramming: Recent Advancement and Future Challenges. Cells, 8.10.3390/cells8101189 ↗
93. Computational approaches for predicting key transcription factors in targeted cell reprogramming (Review)
94. Developmental Basis of Vascular Smooth Muscle Diversity10.1161/ATVBAHA.107.141069 ↗
95. Origin and differentiation of vascular smooth muscle cells10.1113/JP270033 ↗
96. Generation of Vascular Smooth Muscle Cells From Induced Pluripotent Stem Cells10.1161/CIRCRESAHA.120.318049 ↗
97. Smooth Muscle Lineage Diversity in the Chick Embryo. Two types of aortic smooth muscle cell differ in growth and receptor-mediated transcriptional responses to transforming growth factor-beta10.1006/dbio.1996.0229 ↗
98. In vitro differences between venous and arterial-derived smooth muscle cells: Potential modulatory role of decorin10.1016/j.cardiores.2004.10.012 ↗
99. Engineered 3D vessel-on-chip using hiPSC-derived endothelial- and vascular smooth muscle cells10.1016/j.stemcr.2021.08.003 ↗
100. Yao, M., Ren, T., Pan, Y., Xue, X., Li, R., Zhang, L., Li, Y., and Huang, K. (2022). A New Generation of Lineage Tracing Dynamically Records Cell Fate Choices. Int. J. Mol. Sci., 23.10.3390/ijms23095021 ↗